Klor-con Tablet, Film Coated, Extended Release
Product Images NDC 0245-5315

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Klor-con (NDC 0245-5315). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Upsher-smith Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (600 mg Tablet Bottle Label)

Label for Klor-Con 8 extended-release tablets, containing potassium chloride 600 mg (equivalent to 8 mEq potassium). The label indicates 100 tablets in the package, Rx only, manufactured by Upsher-Smith Laboratories, LLC. It includes storage instructions and a barcode.*

FDA Label Image

Principal Display Panel (750 mg Tablet Bottle Label)

Label for Klor-Con 10 potassium chloride extended-release tablets, USP, 750 mg (10 mEq) strength. The label states the product contains 100 tablets for oral use and is manufactured by Upsher-Smith Laboratories, LLC. Dosage and storage instructions are included, along with safety warnings and trademark information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.